DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparison of Continuation Rates

Information source: Emory University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Continuation Rates of Birth Control

Phase: N/A

Status: Active, not recruiting

Sponsored by: Emory University

Official(s) and/or principal investigator(s):
Carrie Cwiak, MD, MPH, Principal Investigator, Affiliation: Emory University

Summary

This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion.

Clinical Details

Official title: A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods (Oral Contraceptive Pills, Depo Provera and Ortho Evra) Among Women Seeking First Trimester Abortion.

Study design: Natural History, Longitudinal, Convenience Sample, Prospective Study

Detailed description: Unintended pregnancy rates among women in the United States continue to surpass that of the rest of the developed world at great cost to society. Contraceptive failure has been attributed to poor compliance with contraceptive methods and results in unintended pregnancies. This study will evaluate the 3-month continuation rates among women using the oral contraceptive pill and Depo-Provera. It will also assess the continuation rates of Ortho Evra®, which has not previously been studied in the adolescent population. This study will provide information with regard to pregnancy rates and 3-month patterns of use of contraception among women seeking first-trimester abortion. It will also assess other factors contributing to successful contraception such as the use of emergency contraception and concomitant condom use. The results of this study will be used to inform the practice of providers who provide reproductive health care to women and add to the sparse body of literature available comparing the success of different contraceptive methods used by women.

Eligibility

Minimum age: 18 Years. Maximum age: 45 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Age 13-45 presents at the ambulatory surgery at Grady Memorial Hospital Want to use

either oral contraceptive pills, ortho evra or depo provera?

Exclusion Criteria:

- Leaving the Atlanta area within 6 months? Desires pregnancy within the next 6 months?

Unable to provide contact information? contraindications to hormonal contraceptive.

Locations and Contacts

Grady Memorial Hospital, Atlanta, Georgia 30303, United States
Additional Information

Starting date: October 2004
Last updated: April 19, 2006

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009